Personal profile
Education/Academic qualification
Post Doctoral Fellow, University Of Wisconsin-Madison
2009
Residency, University Of Wisconsin-Madison
2006
Residency, University Children's Hospital - Skopje Republic of Macedonia
1990
Doctor of Medicine, University Cyril And Methodius
1982
-
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Wurth, M. (PI), Anstead, M. (CoI) & Danov, Z. (Former PI)
6/16/22 → 4/3/27
Project: Research project
-
A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)
Anstead, M. (PI), Kanga, J. (CoI) & Danov, Z. (Former CoI)
Seattle Childrens Research Institute
4/1/21 → 2/15/27
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Wurth, M. (PI), Anstead, M. (CoI) & Danov, Z. (Former PI)
9/2/22 → 5/25/24
Project: Research project
-
Cystic Fibrosis Center Program FY23 - Pediatrics Portion
Kanga, J. (PI), Danov, Z. (CoI) & Wurth, M. (CoI)
7/1/22 → 6/30/23
Project: Research project
-
Therapeutic Development Center FY24
Wurth, M. (PI), Anstead, M. (CoI), Kanga, J. (CoI), Kuhn, R. (CoI), Ramdial, F. (CoI) & Danov, Z. (Former CoI)
4/1/22 → 6/30/24
Project: Research project